The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Natural products and drug discovery: Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia?
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goffeau, A., Barrell, B. G., Bussey, H., Davis, R. W., Dujon, B., Feldmann, H., Galibert, F., Hoheisel, J. D., Jacq, C., Johnston, M., et al. (1996) · Science · doi:10.1126/science.274.5287.546 · Cited by 4,263
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery
Schreiber, S. L. (2000) · Science · doi:10.1126/science.287.5460.1964 · Cited by 2,568
Curcumin as “Curecumin”: From kitchen to clinic
Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,214
Handelsman, J., Rondon, M. R., Brady, S. F., Clardy, J., & Goodman, R. M. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90108-9 · Cited by 1,998
Natural products in drug discovery
Harvey, A. L. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.004 · Cited by 1,832
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen
Mayer, T. U., Kapoor, T. M., Haggarty, S. J., King, R. W., Schreiber, S. L., & Mitchison, T. J. (1999) · Science · doi:10.1126/science.286.5441.971 · Cited by 1,727
Taxol and Taxane Production by Taxomyces andreanae , an Endophytic Fungus of Pacific Yew
Stierle, A., Strobel, G., & Stierle, D. (1993) · Science · doi:10.1126/science.8097061 · Cited by 1,701
Alberts, A. W., Chen, J., Kuron, G., Hunt, V, Huff, J., Hoffman, C., Rothrock, J., Lopez, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,628
Natural Products in Drug Discovery and Development
Cragg, G. M., Newman, D. J., & Snader, K. M. (1997) · Journal of Natural Products · doi:10.1021/np9604893 · Cited by 1,585
Biological effects of cyclosporin A: A new antilymphocytic agent
Borel, J. F., Feurer, C., Gubler, H. U., & Stähelin, H. (1976) · Agents and Actions · doi:10.1007/bf01973261 · Cited by 1,509
The fungal dimension of biodiversity: magnitude, significance, and conservation
Hawksworth, D. L. (1991) · Mycological Research · doi:10.1016/s0953-7562(09)80810-1 · Cited by 1,475
Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective
Wink, M. (2003) · Phytochemistry · doi:10.1016/s0031-9422(03)00300-5 · Cited by 1,449
The influence of natural products upon drug discovery (Antiquity to late 1999)
Newman, D. J., Cragg, G. M., & Snader, K. M. (2000) · Natural Product Reports · doi:10.1039/a902202c · Cited by 1,293
KINO, T., HATANAKA, H., HASHIMOTO, M., NISHIYAMA, M., GOTO, T., OKUHARA, M., KOHSAKA, M., AOKI, H., & IMANAKA, H. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1249 · Cited by 1,241
Multi-target therapeutics: when the whole is greater than the sum of the parts
Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097
ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.
ENDO, A., KURODA, M., & TSUJITA, Y. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.1346 · Cited by 954
Modular Organization of Genes Required for Complex Polyketide Biosynthesis
Donadio, S., Staver, M. J., McAlpine, J. B., Swanson, S. J., & Katz, L. (1991) · Science · doi:10.1126/science.2024119 · Cited by 898
Acetylcholinesterase inhibitors from plants
Mukherjee, P. K., Kumar, V., Mal, M., & Houghton, P. J. (2007) · Phytomedicine · doi:10.1016/j.phymed.2007.02.002 · Cited by 809
The efficiency of multi-target drugs: the network approach might help drug design
CSERMELY, P., AGOSTON, V, & PONGOR, S. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.02.007 · Cited by 803
Zengler, K., Toledo, G., Rappé, M., Elkins, J., Mathur, E. J., Short, J. M., & Keller, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252630999 · Cited by 796
Multicomponent therapeutics for networked systems
Keith, C. T., Borisy, A. A., & Stockwell, B. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1609 · Cited by 769
Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., & Lewis, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030540597 · Cited by 761
Goldmann, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530270074035 · Cited by 753
Wang, L., Zhou, G.-B., Liu, P., Song, J.-H., Liang, Y., Yan, X.-J., Xu, F., Wang, B.-S., Mao, J.-H., Shen, Z.-X., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712365105 · Cited by 733
Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?
Newman, D. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0704090 · Cited by 716
The Practice of Medicinal Chemistry
(2003) · Elsevier eBooks · doi:10.1016/b978-0-12-744481-9.x5000-4 · Cited by 702
Modulation of Polyketide Synthase Activity by Accessory Proteins During Lovastatin Biosynthesis
Kennedy, J., Auclair, K., Kendrew, S. G., Park, C., Vederas, J. C., & Richard Hutchinson, C. (1999) · Science · doi:10.1126/science.284.5418.1368 · Cited by 654
Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and Trials
Corson, T. W., & Crews, C. M. (2007) · Cell · doi:10.1016/j.cell.2007.08.021 · Cited by 654
Flavonoids as developmental regulators
Taylor, L. P., & Grotewold, E. (2005) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2005.03.005 · Cited by 646
GERTH, K., BEDORF, N., HÖFLE, G., IRSCHIK, H., & REICHENBACH, H. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.560 · Cited by 631
Medicinal Plants and Phytomedicines. Linking Plant Biochemistry and Physiology to Human Health
Briskin, D. P. (2000) · Plant Physiology · doi:10.1104/pp.124.2.507 · Cited by 602
Phosphonomycin, a New Antibiotic Produced by Strains of Streptomyces
Hendlin, D., Stapley, E. O., Jackson, M., Wallick, H., Miller, A. K., Wolf, F. J., Miller, T. W., Chaiet, L., Kahan, F. M., Foltz, E. L., et al. (1969) · Science · doi:10.1126/science.166.3901.122 · Cited by 593
Mitomycin C: small, fast and deadly (but very selective)
Tomasz, M. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90120-5 · Cited by 581
Emergence of Drug-Resistant Pneumococcal Infections in the United States
Breiman, R. F. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510470035031 · Cited by 562
Ondetti, M. A., Williams, N. J., Sabo, E., Pluscec, J., Weaver, E. R., & Kocy, O. (1971) · Biochemistry · doi:10.1021/bi00798a004 · Cited by 521
Total bacterial diversity in soil and sediment communities—A review
Torsvik, V, Sørheim, R., & Goksøyr, J. (1996) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/bf01574690 · Cited by 517
Kowalski, R. J., Giannakakou, P., & Hamel, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2534 · Cited by 511
Howden, B. P., Ward, P. B., Charles, P. G. P., Korman, T. M., Fuller, A., Cros, P. D., Grabsch, E. A., Roberts, S. A., Robson, J., Read, K., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/381202 · Cited by 484
Taxol: an antimitotic agent with a new mechanism of action
Manfredi, J. J., & Horwitz, S. B. (1984) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(84)90025-1 · Cited by 483
Search and Discovery Strategies for Biotechnology: the Paradigm Shift
Bull, A. T., Ward, A. C., & Goodfellow, M. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.3.573-606.2000 · Cited by 477
Breinbauer, R., Vetter, I. R., & Waldmann, H. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020816)41:16<2878::aid-anie2878>3.0.co;2-b · Cited by 475
Chemistry and Biochemistry of Microbial α‐Glucosidase Inhibitors
Truscheit, E., Frommer, W., Junge, B., Müller, L., Schmidt, D. D., & Wingender, W. (1981) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198107441 · Cited by 472
The Vancomycin Group of Antibiotics and the Fight against Resistant Bacteria
Williams, D. H., & Bardsley, B. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990503)38:9<1172::aid-anie1172>3.0.co;2-c · Cited by 468
McDaniel, R., Thamchaipenet, A., Gustafsson, C., Fu, H., Betlach, M., Betlach, M., & Ashley, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1846 · Cited by 463
Cloning and Heterologous Expression of the Epothilone Gene Cluster
Tang, L., Shah, S., Chung, L., Carney, J., Katz, L., Khosla, C., & Julien, B. (2000) · Science · doi:10.1126/science.287.5453.640 · Cited by 424
Petersen, P. J., Jacobus, N. V., Weiss, W. J., Sum, P. E., & Testa, R. T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.738 · Cited by 415
The value of natural products to future pharmaceutical discovery
Baker, D. D., Chu, M., Oza, U., & Rajgarhia, V. (2007) · Natural Product Reports · doi:10.1039/b602241n · Cited by 413
Rollini, M. M. (2002) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-002-0932-9 · Cited by 410
FK506 and cyclosporin, molecular probes for studying intracellular signal transduction
Liu, J. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90048-p · Cited by 383
Natural Products as a Resource for New Drugs
Clark, A. M. (1996) · Pharmaceutical Research · doi:10.1023/a:1016091631721 · Cited by 378
Shanidar IV, a Neanderthal Flower Burial in Northern Iraq
Solecki, R. S. (1975) · Science · doi:10.1126/science.190.4217.880 · Cited by 371
Strategies for optimizing combinations of molecularly targeted anticancer agents
Dancey, J. E., & Chen, H. X. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2089 · Cited by 365
Brown, A. G., Smale, T. C., King, T. J., Hasenkamp, R., & Thompson, R. H. (1976) · Journal of the Chemical Society, Perkin Transactions 1 · doi:10.1039/p19760001165 · Cited by 360
Revisiting the ancient concept of botanical therapeutics
Schmidt, B. M., Ribnicky, D. M., Lipsky, P. E., & Raskin, I. (2007) · Nature Chemical Biology · doi:10.1038/nchembio0707-360 · Cited by 355
The TOR Kinases Link Nutrient Sensing to Cell Growth
Rohde, J., Heitman, J., & Cardenas, M. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r000034200 · Cited by 351
Rational Design of Peptide Antibiotics by Targeted Replacement of Bacterial and Fungal Domains
Stachelhaus, T., Schneider, A., & Marahiel, M. A. (1995) · Science · doi:10.1126/science.7604280 · Cited by 340
Jung, G. (1991) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199110513 · Cited by 331
Vancomycin Derivatives That Inhibit Peptidoglycan Biosynthesis Without Binding d -Ala- d -Ala
Ge, M., Chen, Z., Russell, H., Onishi, Kohler, J., Silver, L. L., Kerns, R., Fukuzawa, S., Thompson, C., & Kahne, D. (1999) · Science · doi:10.1126/science.284.5413.507 · Cited by 318
Carbapenems, a new class of beta-lactam antibiotics
Birnbaum, J., Kahan, F. M., Kropp, H., & Macdonald, J. S. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90097-x · Cited by 301
Xenohormesis: Sensing the Chemical Cues of Other Species
Howitz, K. T., & Sinclair, D. A. (2008) · Cell · doi:10.1016/j.cell.2008.04.019 · Cited by 301
New Directions in Antibacterial Research
Chu, D. T. W., Plattner, J. J., & Katz, L. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960294s · Cited by 298
On the evolution of plant secondary chemical diversity
Jones, C. G., & Firn, R. D. (1991) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1991.0077 · Cited by 273
The value of undiscovered pharmaceuticals in tropical forests
Mendelsohn, R., & Balick, M. J. (1995) · Economic Botany · doi:10.1007/bf02862929 · Cited by 265
Antifungals: mechanism of action and resistance, established and novel drugs
Georgopapadakou, N. H. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80087-8 · Cited by 224
Moellering, R. C., Linden, P. K., Reinhardt, J., Blumberg, E. A., Bompart, F., & Talbot, G. H. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.2.251 · Cited by 218
Target selection in drug discovery
Knowles, J., & Gromo, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd986 · Cited by 216
Antifungal proteins: targets, mechanisms and prospective applications
Theis, T., & Stahl, U. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3231-4 · Cited by 214
Daptomycin: a novel agent for Gram-positive infections
Tally, F. P., Zeckel, M., Wasilewski, M. M., Carini, C., Berman, C. L., Drusano, G. L., & Oleson JR, F. B. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.8.1223 · Cited by 205
Resisting resistance: new chemical strategies for battling superbugs
Wright, G. D. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00126-5 · Cited by 203
Agouridas, C., Denis, A., Auger, J.-M., Benedetti, Y., Bonnefoy, A., Bretin, F., Chantot, J., Dussarat, A., Fromentin, C., D'Ambrières, S. G., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980240d · Cited by 201
Denis, A., Agouridas, C., Auger, J.-M., Benedetti, Y., Bonnefoy, A., Bretin, F., Chantot, J.-F., Dussarat, A., Fromentin, C., Gouin D'Ambrières, S., et al. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00534-x · Cited by 196
Antineoplastic agents from natural sources: achievements and future directions
Cragg, G. M., & Newman, D. J. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.12.2783 · Cited by 190
An erythromycin analog produced by reprogramming of polyketide synthesis.
Donadio, S., McAlpine, J. B., Sheldon, P. J., JACKSON, M., & Katz, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7119 · Cited by 188
Stapley, E. O., Jackson, M., Hernandez, S., Zimmerman, S. B., Currie, S. A., Mochales, S., Mata, J. M., Woodruff, H. B., & Hendlin, D. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.3.122 · Cited by 177
Clindamycin as an Antimalarial Drug: Review of Clinical Trials
Lell, B., & Kremsner, P. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2315-2320.2002 · Cited by 166
Cruz, M. C., Goldstein, A. L., Blankenship, J., Del Poeta, M., Perfect, J. R., McCusker, J. H., Bennani, Y. L., Cardenas, M. E., & Heitman, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.3162-3170.2001 · Cited by 159
Ancient-modern concordance in Ayurvedic plants: some examples.
Dev, S. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107783 · Cited by 159
Where is the hope for drug discovery? Let history tell the future
De, K., Li, X., & Zhang, H. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.07.002 · Cited by 158
Self-citationJohn, A. R. O., Poeta, M. D., Perfect, J. R., & Heitman, J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.156 · Cited by 155
Antifungal Resistance Trends Towards the Year 2000: Implications for Therapy and New Approaches
Alexander, B. D., & Perfect, J. R. (1997) · Drugs · doi:10.2165/00003495-199754050-00002 · Cited by 153
Update on antifungals targeted to the cell wall: focus on β-1,3-glucan synthase inhibitors
Georgopapadakou, N. H. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.2.269 · Cited by 149
Arceci, R. J., Stieglitz, K. A., & Bierer, B. E. (1992) · Blood · doi:10.1182/blood.v80.6.1528.1528 · Cited by 140
Cruz, M. C., Poeta, M. D., Wang, P., Wenger, R. M., Zenke, G., Quesniaux, V. F. J., Movva, N. R., Perfect, J. R., Cardenas, M. E., & Heitman, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.143-149.2000 · Cited by 138
The Impact of Arabidopsis on Human Health: Diversifying Our Portfolio
Jones, A. M., Chory, J., Dangl, J. L., Estelle, M. A., Jacobsen, S. E., Meyerowitz, E. M., Nordborg, M., & Weigel, D. (2008) · Cell · doi:10.1016/j.cell.2008.05.040 · Cited by 136
The post-genomic era of interactive proteomics: Facts and perspectives
Auerbach, D., Thaminy, S., Hottiger, M. O., & Štagljar, I. (2002) · PROTEOMICS · doi:10.1002/1615-9861(200206)2:6<611::aid-prot611>3.0.co;2-y · Cited by 133
CAVALLERI, B., PAGANI, H., Volpe, G., Selva, E., & Parenti, F. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.309 · Cited by 128
Pneumocandins from Zalerion arboricola. I. Discovery and isolation.
Schwartz, R. E., Sesin, D. F., JOSHUA, H., et al. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.1853 · Cited by 127
The history of cyclosporin A (Sandimmune®) revisited: Another point of view
Stähelin, H. (1996) · Cellular and Molecular Life Sciences · doi:10.1007/bf01922409 · Cited by 120
An array of target-specific screening strains for antibacterial discovery
DeVito, J. A., Mills, J. A., Liu, V. G., Agarwal, A., Sizemore, C. F., Yao, Z., Stoughton, D., Cappiello, M. G., Barbosa, M. D. F. S., Foster, L. A., et al. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-478 · Cited by 115
Yang, S. S., Cragg, G. M. L., Newman, D. J., & Bader, J. P. (2001) · Journal of Natural Products · doi:10.1021/np0003995 · Cited by 110
Genomics and Antimicrobial Drug Discovery
Moir, D. T., Shaw, K. J., Hare, R. S., & Vovis, G. F. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.439 · Cited by 106
Marine Microorganisms: A New Biomedical Resource
Fenical, W., & Jensen, P. R. (1993) · Springer eBooks · doi:10.1007/978-1-4899-2391-2_12 · Cited by 100
Ji, H., & Zhang, H. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00752.x · Cited by 96
Self-citationNatural Compounds: Leads or Ideas? Bioinspired Molecules for Drug Discovery
Beghyn, T. B., Deprez-Poulain, R. F., Willand, N., Folléas, B., & Deprez, B. P. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00673.x · Cited by 95
Epp, J. K., Huber, M. L. B., Turner, J. R., Goodson, T. G., III, & Schoner, B. E. (1989) · Gene · doi:10.1016/0378-1119(89)90421-6 · Cited by 95
Combinatorial biosynthesis of antimicrobials and other natural products
Rodríguez, E. (2001) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00246-0 · Cited by 94
DiDomenico, B. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00009-0 · Cited by 93
Differential genome analysis applied to the species‐specific features of Helicobacter pylori
Huynen, M. A., Dandekar, T., & Peer Bork, B. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00276-2 · Cited by 85
2007 FDA drug approvals: a year of flux
Hughes, B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2514 · Cited by 82
Natural Product Guided Compound Library Development
Breinbauer, R., Manger, M., Scheck, M., & Waldmann, H. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023368773 · Cited by 82
Realism in drug discovery—could Cassandra be right?
Horrobin, D. F. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1099 · Cited by 79
Production of statins by filamentous fungi
Manzoni, M., Bergomi, S., Rollini, M., & Cavazzoni, V. (1999) · Biotechnology Letters · doi:10.1023/a:1005495714248 · Cited by 78
Ascomycins: promising agents for the treatment of inflammatory skin diseases
Paul, C. F., Graeber, M., & Stuetz, A. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.1.69 · Cited by 76
Biosynthesis and Molecular Genetics of Clavulanic Acid
Jensen, S. E., & Paradkar, A. S. (1999) · Antonie van Leeuwenhoek · doi:10.1023/a:1001755724055 · Cited by 72
New drug development in the United States from 1963 to 1992
DiMasi, J. A., Seibring, M., & Lasagna, L. C. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.78 · Cited by 72
Recent Developments in Tetracycline Antibiotics
Sum, P., Sum, F. W., & Projan, S. J. (1970) · Current Pharmaceutical Design · doi:10.2174/138161280401221007113202 · Cited by 71
Evidence for Life on Earth More Than 3850 Million Years Ago
Holland, H. D. (1997) · Science · doi:10.1126/science.275.5296.38 · Cited by 69
Digoxin remains useful in the management of chronic heart failure
DEC, G. W. (2003) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00172-4 · Cited by 69
Caspofungin acetate: An antifungal agent
Hoang, A. D. (2001) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/58.13.1206 · Cited by 68
Hara, O., & Hutchinson, C. R. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.15.5141-5144.1992 · Cited by 66
Ji, H., De, K., Shen, L., Chen, L., Ma, B., & Zhang, H. (2007) · Genome biology · doi:10.1186/gb-2007-8-8-r176 · Cited by 61
Self-citationNovel targets for the future development of antibacterial agents
McDevitt, D., Payne, D. J., Holmes, D. J., & Rosenberg, M. J. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.16.x · Cited by 60
Synergy in natural medicines: implications for drug discovery
Li, X., & Zhang, H. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.04.002 · Cited by 60
Self-citationPrescription for an ailing pharmaceutical industry
Demain, A. L. (2002) · Nature Biotechnology · doi:10.1038/nbt0402-331 · Cited by 58
The industrialization of drug discovery
Handen, J. S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02099-2 · Cited by 54
Hunter, P. (2008) · EMBO Reports · doi:10.1038/embor.2008.160 · Cited by 48
Commentary: “A systems view on the future of medicine: Inspiration from Chinese medicine?”
Verpoorte, R., Crommelin, D. J. A., Danhof, M., Gilissen, L. J. W., Schuitmaker, H., van der Greef, J., & Witkamp, R. F. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.11.005 · Cited by 47
Clavulanic acid, a novel beta-lactamase inhibitor--a case study in drug discovery and development.
BROWN, A. G. (1986) · PubMed · Cited by 47
GENETICALLY ENGINEERED SYNTHESIS OF NATURAL PRODUCTS: From Alkaloids to Corrins
Roessner, C. A., & Scott, A. I. (1996) · Annual Review of Microbiology · doi:10.1146/annurev.micro.50.1.467 · Cited by 46
Durán, N., Justo, G. Z., Melo, P. S., AZEVEDO, M. B. M. D., Brito, A. R. M. S., de Almeida, A. B. A., & Haun, M. (2003) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y03-033 · Cited by 45
Quinupristin/dalfopristin: therapeutic potential for vancomycin-resistant enterococcal infections
Moellering, R. C. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.suppl_1.25 · Cited by 44
De, K., Li, X., Tang, G.-Y., & Zhang, H. (2007) · ChemMedChem · doi:10.1002/cmdc.200700291 · Cited by 43
Self-citationTelithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections
Yassin, H. M., & Dever, L. L. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.2.353 · Cited by 43
Bacterial protein secretion — a target for new antibiotics?
Stephens, C. M., & Shapiro, L. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90217-9 · Cited by 38
Identification of Protein Fold Topology Shared between Different Folds Inhibited by Natural Products
McArdle, B. M., & Quinn, R. J. (2007) · ChemBioChem · doi:10.1002/cbic.200700035 · Cited by 38
Mother nature's combinatorial libraries; their influence on the synthesis of drugs.
Kingston, D. G. I., & Newman, D. J. (2002) · PubMed · Cited by 34
ABT-773: a new ketolide antibiotic
Dougherty, T. J., & Barrett, J. F. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.2.343 · Cited by 33
BRENNAN, M. B. (2000) · Chemical & Engineering News · doi:10.1021/cen-v078n023.p063 · Cited by 33
Bartolomeo Gosio, 1863–1944: An appreciation
Bentley, R. (2001) · Advances in applied microbiology · doi:10.1016/s0065-2164(01)48005-1 · Cited by 24
Antibiotics from Genetically Engineered Microorganisms
Hutchinson, C. R. (1997) · Drugs and the pharmaceutical sciences · doi:10.1201/b14856-23 · Cited by 21
A new hydroxylase system in Actinomadura sp cells converting compactin to pravastatin
Peng, Y., & Demain, A. L. (1998) · Journal of Industrial Microbiology & Biotechnology · doi:10.1038/sj.jim.2900539 · Cited by 19
The echinocandins: antifungals targeted to the fungal cell wall
Debono, M. (1994) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.3.8.821 · Cited by 16
Thayer, A. M. (2000) · Chemical & Engineering News · doi:10.1021/cen-v078n045.p020 · Cited by 15
Rediscovering the role of natural products in drug discovery.
Desai, M. C., & Chackalamannil, S. (2008) · PubMed · Cited by 12
ORGANIC LAB SPARKS DRUG DISCOVERY
BORMAN, S. (2002) · Chemical & Engineering News · doi:10.1021/cen-v080n002.p023 · Cited by 12
Tacrolimus and Other Immunosuppressive Macrolides in Clinical Practice
Amaya, T., Hiroi, J., & Lawrence, I. D. (2003) · Elsevier eBooks · doi:10.1016/b978-012526451-8/50010-2 · Cited by 8
Convergent Evolution of Medicines
De, K., Li, X., & Zhang, H. (2008) · ChemMedChem · doi:10.1002/cmdc.200800093 · Cited by 7
Self-citation(1999) · doi:10.1002/(sici)1521-3773(19990301)38:5<643::aid-anie643>3.0.co;2-g
Cited by
Metal complexes in cancer therapy – an update from drug design perspective
Ndagi, U., Mhlongo, N., & Soliman, M. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s119488 · Cited by 935
Chemical Ecology of Endophytic Fungi: Origins of Secondary Metabolites
Kusari, S., Hertweck, C., & Spiteller, M. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.06.004 · Cited by 743
Afendi, F. M., Okada, T., Yamazaki, M., Hirai-Morita, A., Nakamura, Y., Nakamura, K., Ikeda, S., Takahashi, H., Altaf-Ul-Amin, M., Darusman, L. K., et al. (2012) · Plant and Cell Physiology · doi:10.1093/pcp/pcr165 · Cited by 738
Network Pharmacology Approach for Medicinal Plants: Review and Assessment
Noor, F., Tahir ul Qamar, M., Ashfaq, U. A., Albutti, A., Alwashmi, A. S. S., & Aljasir, M. A. (2022) · Pharmaceuticals · doi:10.3390/ph15050572 · Cited by 540
Chen, S., Wang, X., Cheng, Y., Gao, H., & Chen, X. (2023) · Molecules · doi:10.3390/molecules28134982 · Cited by 465
Metadata
- Authors
- Ji, H., Li, X., & Zhang, H.
- Venue
- EMBO reports
- Published
- 2009-02-20
- Volume
- 10
- Issue
- 3
- Pages
- 194-200
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- OpenAlex
- W2147798082
- Cited by
- 636
- References
- 141
- FWCI
- 18.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.